Women's Health Initiative Estrogen Study

What is the women's health Initiative study?

The Women's Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), is a long-term national health study that focuses on strategies for preventing heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women.

Women's Health Initiative (WHI) | NHLBI, NIH

What were the results of the women's health Initiative concerning hormone therapy?

WHI results in 2002 found that post-menopausal women taking combination (estrogen and progestin) hormone therapy for menopause symptoms had an increased risk for breast cancer, heart disease, stroke, blood clots, and urinary incontinence.

Largest women's health prevention study ever

When did the women's health Initiative study end?

As has been described in the objective, the WHI has three major components: a randomized controlled clinical trial, an observational study, and a study of community approaches to developing healthful behaviors. Recruitment for the WHI began in September 1993 and ended in December 1998.

Women's Health Initiative (WHI) - Full Text View - ClinicalTrials.gov

Why was the WHI study terminated early?

One treatment-arm of the Women's Health Initiative (WHI) study was recently terminated because the overall risks of hormone treatment were considered to outweigh the benefits. The main findings were an increased risk of venous thromboembolism and a decreased risk of osteoporotic fractures with treatment.

[After the early termination of the Women's Health Initiative study ...